Xiidra Approved; Pending Effective Date

Posted in Latest News on September 14, 2016.

At the August 19, 2016 Board of Optometry meeting, the board voted and approved the use of Xiidra (Lifitegrast ophthalmic solution 5%) for dry eyes. The formulary rule is in the process of being changed to include Lifitegrast ophthalmic solution 5%.

Until the new rule becomes effective, Florida Optometrists are not allowed to prescribe the medication. The board will place a notification on the website advising when the addition to the rule has become effective.



More Latest News

Fourth Quarter Performance Report
September 2, 2022

Released for the
2021 – 2022 Fiscal Year Continue reading


Website Server Maintenance Notice
July 5, 2022

Please be aware of website server maintenance for MQA Websites beginning Friday, July 8th at 5:00PM EST. Click here for more information. Continue reading